首页> 外文期刊>Kidney international. >Induction of VEGF and VEGF receptor gene expression by hypoxia: Divergent regulation in vivo and in vitro
【24h】

Induction of VEGF and VEGF receptor gene expression by hypoxia: Divergent regulation in vivo and in vitro

机译:低氧诱导VEGF和VEGF受体基因表达的体内外差异性调控

获取原文
           

摘要

Induction of VEGF and VEGF receptor gene expression by hypoxia: Divergent regulation in vivo and in vitro. This study examined the expression of EPO,VEGF and VEGF receptor gene under conditions of reduced oxygen supply in primary cultures of rat hepatocytes, and compared it with the expression of these genes in hypoxic rat livers in vivo. To this end we exposed male Sprague-Dawley rats to hypoxia (10% and 8% O2), carbon monoxide (0.1% CO) or injected cobalt chloride (60 mg/kg CoCl2) subcutaneously. For the in vitro experiments we used primary cultures of rat hepatocytes which were kept at high (20% O2) and low (1% O2) oxygen tensions for three hours. The EPO mRNA was up-regulated by hypoxia in vitro and in vivo about 10-fold. The VEGF mRNA was up-regulated fivefold in the hepatocytes only, whereas the in vivo mRNA levels remained unchanged. The mRNA levels of flt-1 were up-regulated threefold by 8% O2 in livers, dependent on the strength of hypoxia (10% caused no changes in flt-1 gene expression) and on the kind of hypoxic stimulus (8% O2 was as effective as 0.1% CO and more effective than cobalt). The mRNA levels of flk-1/KDR and flt-4 remained unchanged in the liver. In vitro there were no changes in the mRNA levels of flt-1, flt-4 and flk-1/KDR. Consequently, the in vivo regulation of VEGF, which might be modulated by induction of flt-1 receptor gene expression, differs from the in vitro cell culture situation and might be different from the EPO regulationin vivo
机译:低氧诱导的VEGF和VEGF受体基因表达:体内和体外的不同调节。这项研究检查了在大鼠肝细胞原代培养中供氧减少的条件下EPO,VEGF和VEGF受体基因的表达,并将其与这些基因在体内低氧大鼠肝脏中的表达进行了比较。为此,我们将雄性Sprague-Dawley大鼠暴露于低氧(10%和8%O2),一氧化碳(0.1 %% CO)或皮下注射氯化钴(60 mg / kg CoCl2)。对于体外实验,我们使用大鼠肝细胞的原代培养物,将其在高(20%O2)和低(1%O2)的氧气张力下保持三个小时。 EPO mRNA在体内和体外被缺氧上调约10倍。 VEGF mRNA仅在肝细胞中上调五倍,而体内mRNA水平则保持不变。肝脏中flt-1的mRNA水平被8%的O2上调了三倍,这取决于缺氧的强度(10%的flt-1基因表达没有变化)和缺氧刺激的种类(8 %O2与0.1%CO一样有效,并且比钴更有效。肝脏中flk-1 / KDR和flt-4的mRNA水平保持不变。在体外,flt-1,flt-4和flk-1 / KDR的mRNA水平没有变化。因此,可能通过诱导flt-1受体基因表达来调节VEGF的体内调节不同于体外细胞培养情况,并且可能不同于体内EPO调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号